Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b.
Benjamini
Ohad
O
Department of Medicine A, Meir Medical Center, Kfar Saba, Israel.
Kimhi
Oded
O
Lishner
Michael
M
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000209:etiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D010493:Pericarditis / Q000139:chemically induced* / Q000209:etiology; D011994:Recombinant Proteins; D012307:Risk Factors
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins